Orgovyx is typically taken for at least one year, and many patients stay on it longer depending on how their cancer responds. There is no fixed end date built into the prescription. Your oncologist determines how long you continue based on your specific cancer stage, PSA levels, and treatment goals.
Standard Treatment Duration
In the pivotal clinical trial that led to FDA approval (the HERO trial), patients took Orgovyx continuously for 48 weeks, which is just under a year. To enroll, they had to be candidates for at least one year of continuous hormone therapy. That 48-week mark is the best-studied timeframe, and it showed that 97% of men maintained testosterone suppression throughout.
In practice, many men take Orgovyx for longer than a year. Advanced prostate cancer often requires ongoing hormone therapy for two to three years, or even indefinitely if the cancer is metastatic. Some men with earlier-stage disease use it for a defined period alongside radiation therapy, sometimes six months to two years. Your oncologist will reassess at regular intervals whether continuing makes sense based on your PSA trend and imaging results.
How the Daily Dosing Works
Orgovyx starts with a one-time loading dose of three tablets (360 mg total) on the first day. After that, you take one 120 mg tablet once daily at roughly the same time each day. Unlike injectable hormone therapies that require an office visit every one to three months, Orgovyx is an oral pill you take at home. Consistency matters: missing doses can allow testosterone to rise, which could fuel cancer growth.
What Happens When You Stop
One of Orgovyx’s advantages over older injectable hormone therapies is faster testosterone recovery after stopping. In the HERO trial, men who completed 48 weeks of Orgovyx saw their testosterone return to normal levels in a median of 86 days, roughly three months. By comparison, men on the injectable drug leuprolide took a median of 112 days. More striking, 54% of the Orgovyx group had recovered testosterone within the 90-day follow-up window, versus just 3% of the injection group.
This faster recovery can matter for quality of life. Many of the side effects of hormone therapy, including fatigue, hot flashes, and loss of muscle mass, are directly tied to low testosterone. A quicker rebound means those effects tend to resolve sooner once treatment ends.
Side Effects During Treatment
The most common side effects are hot flashes, fatigue, general weakness, constipation, and muscle pain. These are largely the same side effects caused by any form of testosterone suppression, not unique to Orgovyx. Most side effects appear early. An analysis of FDA adverse event reports found that the median time of onset was 60 days, with the majority occurring within the first 30 days.
Cardiovascular risk is a concern with all hormone therapies for prostate cancer, but Orgovyx appears to carry less heart risk than traditional injections. In the HERO trial, Orgovyx was associated with a 54% lower risk of major cardiovascular events compared to leuprolide. This difference is particularly relevant for men who already have heart disease or risk factors, and it may influence how long your doctor is comfortable keeping you on treatment.
Why Duration Varies Between Patients
The length of treatment depends on several factors that are specific to your situation:
- Cancer stage. Men with metastatic disease often stay on hormone therapy indefinitely, while those with localized or locally advanced cancer may use it for a defined course alongside radiation.
- Treatment response. If your PSA drops to undetectable levels and stays there, your oncologist may discuss stopping at a planned point. If PSA rises or the cancer shows signs of progression, treatment continues or changes.
- Side effect tolerance. Some men experience significant quality-of-life impacts from prolonged testosterone suppression. In those cases, doctors sometimes use intermittent therapy, cycling on and off the medication, though this approach is not appropriate for every patient.
- Combination therapy. When Orgovyx is used alongside radiation or other treatments, the hormone therapy window is often predetermined, commonly 6 months, 18 months, or 2 to 3 years depending on the cancer’s aggressiveness.
Your oncologist will monitor your PSA and testosterone levels at regular intervals throughout treatment. These blood tests are the primary way to confirm the medication is working and to decide when, or whether, it’s safe to stop.